2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders

Details for Australian Patent Application No. 2004272288 (hide)

Owner Novartis AG

Inventors Roesel, Johannes; Imbach, Patricia

Agent Davies Collison Cave

Pub. Number AU-B-2004272288

PCT Pub. Number WO2005/026130

Priority 60/504,374 18.09.03 US

Filing date 17 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 13 November 2008

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026130 Priority application(s): WO2005/026130

13 November 2008 Application Accepted

  Published as AU-B-2004272288

12 March 2009 Standard Patent Sealed

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272289-Therapeutic binding molecules

2004272285-Organic compounds